Abstract: The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.
Type:
Grant
Filed:
February 2, 2008
Date of Patent:
August 7, 2012
Assignee:
Baylore Research Institute
Inventors:
Jacques F. Banchereau, SangKon Oh, Gerard Zurawski, Sandra Zurawski, Dapeng Li